RISKS TO THE RETURNS TO MEDICAL INNOVATION: THE CASE OF MYRIAD GENETICS
Jeffrey Clemens () and
Stan Veuger ()
Contemporary Economic Policy, 2017, vol. 35, issue 2, 345-357
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
Access to full text is restricted to subscribers.
Working Paper: Risks to the Returns to Medical Innovation: The Case of Myriad Genetics (2015)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:bla:coecpo:v:35:y:2017:i:2:p:345-357
Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=1074-3529
Access Statistics for this article
Contemporary Economic Policy is currently edited by Brad R. Humphreys
More articles in Contemporary Economic Policy from Western Economic Association International Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().